CATO26 session covers AI in lung cancer screening, food and risk, and ctDNA-guided therapy
Oncologist Maria Antonia Vélez said on X that discussions at the CATO26 meeting addressed AI in screening, diet and lung cancer risk, and ctDNA.
“Great discussion at #CATO26 today about AI in lung cancer screening, food and lung cancer risk and how to use ctDNA to guide therapy”— Maria Antonia Vélez
Maria Antonia Vélez, who describes herself on X as a head and neck and thoracic oncologist at UCLA, wrote on 7 November 2026 that there had been a "great discussion" at #CATO26 that day.
According to her post, the topics covered were the use of artificial intelligence in lung cancer screening, the relationship between food and lung cancer risk, and how circulating tumour DNA (ctDNA) can be used to guide therapy.
The post is brief and does not name the speakers or session organisers. It also gives no findings, data or conclusions from the discussions, and it does not say what #CATO26 stands for. The post includes a link to an image or other attached content, the details of which are not described in the text.
The account is Vélez's own summary of the discussion, and she notes in her profile that her tweets are her own.
Original source
“Great discussion at #CATO26 today about AI in lung cancer screening, food and lung cancer risk and how to use ctDNA to guide therapy”
— Maria Antonia Vélez View the post on X
